Identification of transmembrane regions critical for ligand binding to the human D3 dopamine receptor using various D3/D1 transmembrane chimeras

Molecular Pharmacology

Volumn 54, Issue 2, 1998, Pages 379-388

  Alberts, Glen L ^a   Pregenzer, Jeffrey F ^a   Im, Wha Bin ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 5 METHOXY 1 METHYLTETRALIN; 5 METHOXY 1 METHYL 2 PROPYLAMINOTETRALIN; APOMORPHINE; BUTACLAMOL; CABERGOLINE; CHLORPROMAZINE; DOPAMINE 3 RECEPTOR; EMONAPRIDE; HALOPERIDOL; LIGAND; LISURIDE; PRAMIPEXOLE; PRECLAMOL; QUINPIROLE; RACLOPRIDE; SPIPERONE;

ANIMAL CELL; ARTICLE; CHIMERA; DISSOCIATION CONSTANT; LEPIDOPTERA; LIGAND BINDING; MEMBRANE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031874219     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.2.379     Document Type: Article

References (20)

1. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
2. Civelli O, Bunzow JR, and Grandy DK (1993) Molecular diversity of the dopamine receptors. Anna Rev Pharmacol Toxicol 32:281-307.
3. Cunningham BC, Jhurani P, Ng P, and Wells JA (1989) Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis. Science (Washington DC) 243:1330-1336.
4. Frielle T, Daniel KW, Caron MG, and Lefkowitz RJ (1988) Structural basis of β-adrenergic receptor subtype specificity studied with chimeric β1/β2-adrenergic receptors. Proc Natl Acad Sci USA 85:9494-9498.
5. Fu D, Ballesteros JA, Weinstein H, Chen J, and Javitch JA (1996) Residues in the seventh membrane-spanning segment of the dopamine D2 receptor accessible in the binding-site crevice. Biochemistry 35:11278-11285.
6. Gingrich JA and Caron MG (1993) Recent advances in the molecular biology of dopamine receptors. Anna Rev Neurosci 16:299-321.
7. Henderson R, Baldwin JM, Ceska TA, Zemlin F, Beckmann E, and Downing KH (1990) Model for the structure of bacteriorhodopsin based on high resolution electron cryo-microscopy. J Mol Biol 213:899-929.
8. Horton RM, Hunt HD, Ho SN, Pullen JK, and Pease LR (1989) Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68.
9. Kebabian JW and Calne DB (1979) Multiple receptors for dopamine. Nature (Lond) 277:93-96.
10. Kozell LB, Machida CA, Neve RL, and Neve KA (1994) Chimeric D1/D2 dopamine receptors. J Biol Chem 269:30299-30306.
11. MacKenzie RG, Steffey ME, Manelli AM, Pollock NJ, and Frail DE (1993) A D1/D2 chimeric dopamine receptor mediates a D1 response to a D2-selective ligand. FEBS Lett 323:59-62.
12. O'Dell SJ, Hoste GJ, Widmark CB, Shapiro RM, Potkin SG, and Marshall JF (1990) Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in the brain. Synapse 6:146-153.
13. Ostrowski J, Kjelsberg MA, Caron MG, and Lefkowitz RJ (1992) Mutagenesis of the β2-adrenergic receptor: how structure elucidates function. Anna Rev Pharmacol Toxicol 32:167-183.
14. 3H]flunitrazepam with cloned γ-aminobutyric acid type A receptors of the α1β2 and α1β2δ2 subtypes. Mol Pharmacol 43:801-806.
15. Schwartz RM and Dayhoff MO (1978) Matrices for detecting distant relationships, in Atlas of Protein Sequence and Structure (Dayhoff MO, ed) pp 353-358, National Biomedical Research Foundation, Washington, DC.
16. Seeman P and Van Tol HHM (1994) Dopamine receptor pharmacology. Trends Pharmacol Sci 15:264-270.
17. Sokoloff P, Giros B, Martres M-P, Bouthenet M-L, and Schwarz J-C (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target of neuroleptics. Nature (Lond) 347:146-151.
18. 3) as a novel target for antipsychotics. Biochem Pharmacol 43:659-666.
19. Sokoloff P and Schwartz J-C (1995) Novel dopamine receptors half a decade later. Trends Pharmacol Sci 16:270-275.
20. Strader CD, Fong TM, Tota MR, and Underwood D (1994) Structure and function of G protein-coupled receptors. Annu Rev Biochem 63:101-132.